Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?

NCT05492149 is registered in ClinicalTrials.gov with Groupe Hospitalier du Havre as lead sponsor.

NCT NCT05492149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05492149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
Lead sponsor
Groupe Hospitalier du Havre
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
December 1, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd exacerbation, pulmonary rehabilitation